Bull Of The Day: High Tide

High Tide (HITI), a cannabis company, is currently a Zacks Rank #2 (Buy) and has reached new 52-week highs, driven by strong growth projections and positive market sentiment regarding potential marijuana rescheduling. Analysts anticipate robust revenue growth of 10.7% to $421M this fiscal year and 29.9% to $548M next fiscal year, with earnings estimates for 2025 and 2026 showing upward revisions. Despite a history of mixed earnings surprises, the company's favorable valuation metrics and the broader industry tailwind from potential regulatory easing position it for continued attention.

Analysis

High Tide Inc. (HITI) is experiencing significant positive momentum, trading at a new 52-week high, underpinned by a compelling growth narrative and favorable industry sentiment. The company's outlook features robust top-line acceleration, with revenue projected to grow 10.7% to $421M this fiscal year and a further 29.9% to $548M in the subsequent year. This is complemented by upward earnings estimate revisions, a key driver for its Zacks Rank #2 (Buy). Specifically, over the last 60 days, the fiscal 2025 loss estimate has narrowed from $0.05 to $0.04, while the 2026 profit estimate has nearly doubled from $0.06 to $0.11 per share. Valuation metrics, including a 0.74x price-to-sales ratio and a 2.9x price-to-book multiple, are presented as attractive relative to peers. However, this forward-looking optimism must be weighed against a history of operational misses, as the company has failed to meet the Zacks Consensus Estimate in three of the last four quarters. The current market enthusiasm is also bolstered by external factors, notably the potential for marijuana rescheduling, which serves as a significant industry-wide catalyst.

Key Decisions for Investors

• Investors with a bullish view on the cannabis sector may find HITI's accelerating revenue growth and improving 2026 profitability outlook compelling, especially given the stock's strong technical momentum.
• Given the company's history of three consecutive earnings misses, the upcoming September 15 report is a critical data point that will test management's ability to execute against heightened analyst expectations.
• While the valuation appears reasonable on a price-to-sales basis, continued performance is necessary to justify the 31x forward P/E on next year's earnings, making consistent delivery on revenue targets essential to sustain the stock's momentum.